↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Maibach Howard I.) ;pers:(Bruze Magnus)"

Sökning: WFRF:(Maibach Howard I.) > Bruze Magnus

Resultat 1-10 av 11

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Alikhan, Ali, et al. (författare) Revised Minimal Baseline Series of the International Contact Dermatitis Research Group: Evidence-Based Approach 2011 Ingår i: Dermatitis. - : Mary Ann Liebert Inc. - 1710-3568. ; 22:2, s. 121-122 Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
2.	Bruze, Magnus, et al. (författare) Patch testing with methylchloroisothiazolinone/methylisothiazolinone 200 ppm aq. detects significantly more contact allergy than 100 ppm. A multicentre study within the European Environmental and Contact Dermatitis Research Group. 2014 Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873. ; 71:1, s. 31-34 Tidskriftsartikel (refereegranskat)abstract Methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI) are the active ingredients in commonly used preservative systems (e.g. Kathon CG(®) ). MCI/MI is present in the European baseline patch test series at 100 ppm aq. Since 1986, 200 ppm (dose 0.006 mg/cm(2) ) has been used in Sweden without causing skin irritation. Centres in Spain, the United Kingdom and Ireland have also used 200 ppm in their baseline series.
3.	Gruvberger, Birgitta, et al. (författare) Methyldibromoglutaronitrile 2003 Ingår i: Management of positive patch test reactions. - 3540443479 ; , s. 41-41 Bokkapitel (övrigt vetenskapligt/konstnärligt)
4.	Isaksson, Marléne, et al. (författare) Multicentre patch testing with methylisothiazolinone by the European Environmental and Contact Dermatitis Research Group. 2014 Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873. ; 70:5, s. 78-317 Tidskriftsartikel (refereegranskat)
5.	Isaksson, Marléne, et al. (författare) Patch Testing To a Textile Dye Mix by the International Contact Dermatitis Research Group. 2015 Ingår i: Dermatitis. - 1710-3568. ; 26:4, s. 170-176 Tidskriftsartikel (refereegranskat)abstract Disperse dyes are well-known contact sensitizers not included in the majority of commercially available baseline series.
6.	Isaksson, Marléne, et al. (författare) Revised Baseline Series of the International Contact Research Group 2020 Ingår i: Dermatitis. - 1710-3568. ; 31:1, s. 5-7 Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
7.	Morgardt-Ryberg, Kristina, et al. (författare) Patch testing with a textile dye mix - a multicentre study. 2014 Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873. ; 71:4, s. 215-223 Tidskriftsartikel (refereegranskat)abstract Disperse dyes are well-known contact sensitizers. However, they are not included in the majority of commercially available baseline patch test series.
8.	Pongpairoj, Korbkarn, et al. (författare) Proposed ICDRG Classification of the Clinical Presentation of Contact Allergy 2016 Ingår i: Dermatitis. - 1710-3568. ; 27:5, s. 248-258 Forskningsöversikt (refereegranskat)abstract The International Contact Dermatitis Research Group proposes a classification for the clinical presentation of contact allergy. The classification is based primarily on the mode of clinical presentation. The categories are direct exposure/contact dermatitis, mimicking or exacerbation of preexisting eczema, multifactorial dermatitis including allergic contact dermatitis, by proxy, mimicking angioedema, airborne contact dermatitis, photo-induced contact dermatitis, systemic contact dermatitis, noneczematous contact dermatitis, contact urticaria, protein contact dermatitis, respiratory/mucosal symptoms, oral contact dermatitis, erythroderma/exfoliative dermatitis, minor forms of presentation, and extracutaneous manifestations.
9.	Pontén, Ann, et al. (författare) Patch testing with 2.0% (0.60 mg/cm(2) ) formaldehyde instead of 1.0% (0.30 mg/cm(2) ) detects significantly more contact allergy. 2013 Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873. ; 68:1, s. 50-53 Tidskriftsartikel (refereegranskat)abstract Background.The currently used patch test concentration for formaldehyde is 1.0% (wt/vol) in water. However, clinical experience and previous studies suggest that 1.0% might be insufficient for detecting an optimized number of clinically relevant cases of contact allergy to formaldehyde. Objectives.To validate earlier patch test results for comparison of 1% (wt/vol) and 2% (wt/vol) formaldehyde in water, and to investigate co-reactivity with quaternium-15. Materials and methods.In 12 dermatology clinics, 3591 patients were routinely patch tested simultaneously with 2.0% (wt/vol) (0.60 mg/cm(2) ) and 1.0% (wt/vol) (0.30 mg/cm(2) ) formaldehyde. Micropipettes were used for delivering the exact dosage of the allergen. Results.Significantly more patients reacted to 2.0% formaldehyde than to 1.0% (3.4% versus 1.8%, p < 0.001). Overall, there were no sex differences between those reacting positively to 2.0% and 1.0%. Of 25 quaternium-15-positive patients, 4 (0.1%) reacted positively without reacting to formaldehyde. Conclusion.On the basis of the results of this multicentre study, as well as of previous studies, it can be suggested that 2.0% (wt/vol) in water formaldehyde should be used in routine patch testing in the baseline series.
10.	Rietschel, Robert L, et al. (författare) The relationship of vehicle and concentration of imidazolidinylurea, with attention to formaldehyde allergy status 2006 Ingår i: Dermatitis. - 1710-3568 .- 2162-5220. ; 17:1, s. 48-49 Tidskriftsartikel (refereegranskat)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-10 av 11

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (9); forskningsöversikt (1); bokkapitel (1)

Typ av innehåll: refereegranskat (8); övrigt vetenskapligt/konstnärligt (3)

Författare/redaktör: Bruze, Magnus (11)Ta bort avgränsningen; Maibach, Howard I. (11); Andersen, Klaus E (7); Goossens, An (6); Goncalo, Margarida (5); Sasseville, Denis (5); visa fler...; Isaksson, Marléne (4); Gruvberger, Birgitta (4); Ale, Iris (4); Goh, Chee Leok (4); Johansen, Jeanne D. (4); Le Coz, Christophe J ... (3); Rustemeyer, Thomas (3); White, Ian R. (3); Lachapelle, Jean-Mar ... (3); Nixon, Rosemary (3); Jerajani, Hemangi (3); Lee, Jun Young (2); Agner, Tove (2); Diepgen, Thomas (2); McFadden, John (2); Puangpet, Pailin (2); Diepgen, Thomas L. (2); Matsunaga, Kayoko (2); Pratt, Melanie (2); Elsner, P (1); Andersen, Klaus Ejne ... (1); Johansen, Jeanne Duu ... (1); Lidén, Carola (1); Alikhan, Ali (1); Cheng, Lily S. (1); Eun, Hee Chul (1); Pharm, An Goossens R ... (1); Niklasson, Bo (1); Foti, Caterina (1); Pontén, Ann (1); Thyssen, Jacob P. (1); Cannavó, Alicia (1); Elsner, Peter (1); Menné, Torkil (1); Gimenez Arnau, Ana (1); Morgardt-Ryberg, Kri ... (1); Kanerva, L (1); Aalto-Korte, Kristii ... (1); Warshaw, Erin M (1); Wahlberg, Jan E (1); Goossens R, An (1); Verma, Kaushal (1); Ljubojevic Hadzavdic ... (1); Bircher, Andreas (1); visa färre...

Lärosäte: Lunds universitet (11); Uppsala universitet (1); Karolinska Institutet (1)

Språk: Engelska (11)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (11)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy